tetano
Editor, Senior Moderator
J Stroke Cerebrovasc Dis
. 2020 Nov;29(11):105283.
doi: 10.1016/j.jstrokecerebrovasdis.2020.105283. Epub 2020 Aug 28.
The Association of Cerebrovascular Disease with Adverse Outcomes in COVID-19 Patients: A Meta-Analysis Based on Adjusted Effect Estimates
Jie Xu[SUP] 1 [/SUP], Wenwei Xiao[SUP] 1 [/SUP], Xuan Liang[SUP] 1 [/SUP], Peihua Zhang[SUP] 1 [/SUP], Li Shi[SUP] 1 [/SUP], Ying Wang[SUP] 1 [/SUP], Yadong Wang[SUP] 2 [/SUP], Haiyan Yang[SUP] 3 [/SUP]
Affiliations
Abstract
Objective: The aim of this study was to address the association between cerebrovascular disease and adverse outcomes in coronavirus disease 2019 (COVID-19) patients by using a quantitative meta-analysis based on adjusted effect estimates.
Method: A systematic search was performed in PubMed, Web of Science, and EMBASE up to August 10th, 2020. The adjusted effect estimates were extracted and pooled to evaluate the risk of the unfavorable outcomes in COVID-19 patients with cerebrovascular disease. Subgroup analysis and meta-regression were also carried out.
Results: There were 12 studies with 10,304 patients included in our meta-analysis. A significant trend was observed when evaluating the association between cerebrovascular disease and adverse outcomes (pooled effect = 2.05, 95% confidence interval (CI): 1.34-3.16). In addition, the pooled effects showed that patients with a history of cerebrovascular disease had more likelihood to progress fatal outcomes than patients without a history of cerebrovascular disease (pooled effect = 1.78, 95% CI: 1.04-3.07).
Conclusion: This study for the first time indicated that cerebrovascular disease was an independent risk factor for predicting the adverse outcomes, particularly fatal outcomes, in COVID-19 patients on the basis of adjusted effect estimates. Well-designed studies with larger sample size are needed for further verification.
Keywords: Adjusted effect estimate; Adverse outcomes; COVID-19; Cerebrovascular disease; Meta-analysis.
. 2020 Nov;29(11):105283.
doi: 10.1016/j.jstrokecerebrovasdis.2020.105283. Epub 2020 Aug 28.
The Association of Cerebrovascular Disease with Adverse Outcomes in COVID-19 Patients: A Meta-Analysis Based on Adjusted Effect Estimates
Jie Xu[SUP] 1 [/SUP], Wenwei Xiao[SUP] 1 [/SUP], Xuan Liang[SUP] 1 [/SUP], Peihua Zhang[SUP] 1 [/SUP], Li Shi[SUP] 1 [/SUP], Ying Wang[SUP] 1 [/SUP], Yadong Wang[SUP] 2 [/SUP], Haiyan Yang[SUP] 3 [/SUP]
Affiliations
- PMID: 33066922
- PMCID: PMC7455117
- DOI: 10.1016/j.jstrokecerebrovasdis.2020.105283
Abstract
Objective: The aim of this study was to address the association between cerebrovascular disease and adverse outcomes in coronavirus disease 2019 (COVID-19) patients by using a quantitative meta-analysis based on adjusted effect estimates.
Method: A systematic search was performed in PubMed, Web of Science, and EMBASE up to August 10th, 2020. The adjusted effect estimates were extracted and pooled to evaluate the risk of the unfavorable outcomes in COVID-19 patients with cerebrovascular disease. Subgroup analysis and meta-regression were also carried out.
Results: There were 12 studies with 10,304 patients included in our meta-analysis. A significant trend was observed when evaluating the association between cerebrovascular disease and adverse outcomes (pooled effect = 2.05, 95% confidence interval (CI): 1.34-3.16). In addition, the pooled effects showed that patients with a history of cerebrovascular disease had more likelihood to progress fatal outcomes than patients without a history of cerebrovascular disease (pooled effect = 1.78, 95% CI: 1.04-3.07).
Conclusion: This study for the first time indicated that cerebrovascular disease was an independent risk factor for predicting the adverse outcomes, particularly fatal outcomes, in COVID-19 patients on the basis of adjusted effect estimates. Well-designed studies with larger sample size are needed for further verification.
Keywords: Adjusted effect estimate; Adverse outcomes; COVID-19; Cerebrovascular disease; Meta-analysis.